Assessing Functional Quality of Single TILs for Correlative Immunotherapy Biomarkers

All Resources

App Note

Learn how using Single-Cell PSI helps you reveal mechanisms in the Tumor Microenvironment.

What's Inside

In this App Note we discuss:

Highlight the challenges in functional characterization of TILs in checkpoint and combination therapies

Describe the workflow for functional single-cell analysis from both solid tumor TILs as well as patient PBMC

Predict patient response to checkpoint therapy using PSI as a biomarker in solid tumor TILs, as well as correlate response from these solid tumor TILs with PSI from peripheral blood

A Deeper Look

More about this App Note

Overcoming Challenges in Checkpoint Combination Therapies

Checkpoint inhibitor blockade therapy has rapidly advanced and is now established as a powerful way to manage various malignant tumors.

Despite the promising outcomes, there are a significant number of patients who do not respond to these immunotherapies.

Download this App Note to learn how PSI helps you overcome these challenges with a wide range of applications in checkpoint and combination therapy research.

Get the App Note

Back to the Top